Apligraf from Organogenesis Inc.

Apligraf is a living bi-layered therapy that is the only product with FDA approval for the treatment of both venous leg ulcers and diabetic foot ulcers. Apligraf is easy to incorporate into practice and has positive reimbursement in all settings. Apligraf has been extensively studied in multiple clinical trials and has been used to treat many thousands of patients.